Neal Rosen, M.D., Ph.D.
Neal Rosen currently serves as Director of the Center for Mechanism-Based Therapeutics at Memorial Sloan-Kettering Cancer Center, where he is also a Member of the Program in Molecular Pharmacology and Chemistry and the Enid A. Haupt Chair in Medical Oncology. Prior to his current role at Memorial Sloan-Kettering Cancer Center, Dr. Rosen held a senior position in the Medicine Branch at the National Cancer Institute. He keenly invests himself in the identification and study of the key molecular events and growth signaling pathways responsible for the development of human cancers, and the use of this information for the development of mechanism-based therapeutic strategies. Dr. Rosen has played a pivotal role in the development of inhibitors of tyrosine kinase-mediated signaling and pioneered the concept that feedback reactivation of parallel signaling pathways is a common cause of adaptive resistance to selective pathway inhibitors. Dr. Rosen earned his undergraduate degree in chemistry from Columbia College and his M.D./Ph.D. in Molecular Biology from the Albert Einstein College of Medicine. He completed a residency in Internal Medicine at Brigham and Women’s Hospital, and postdoctoral training and a fellowship in Medical Oncology at the National Cancer Institute.